Aligos Therapeutics (ALGS) Treasury Shares (2019 - 2026)
Aligos Therapeutics (ALGS) reported Treasury Shares of $80045.0 for Q1 2026, up 363.65% on a YoY basis from $17264.0 in Q1 2025, and up 4.24% quarter-over-quarter from $76786.0 in Q4 2025.
Aligos Therapeutics (ALGS) Treasury Shares (2019 - 2026) Analysis & Trends
Aligos Therapeutics has reported Treasury Shares for 8 years, with the latest figure at $80045.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 363.65% year-over-year to $80045.0; the trailing twelve-month figure through Mar 2026 stood at $80045.0 (up 363.65% YoY), and the FY2025 full-year result was $76786.0, up 1523.73% from the prior year.
- Treasury Shares for Q1 2026 stood at $80045.0, up from $76786.0 in the prior quarter.
- The five-year high for Treasury Shares was $154580.0 in Q1 2024, with the low at $3717.0 in Q2 2022.
- Historically, Treasury Shares has averaged $57767.3 across 5 years, with a median of $21238.0 in 2022.
- Annual changes were most pronounced in 2022 — Treasury Shares slumped 98.35% — and 2025, when it jumped 1635.4%.
- Aligos Therapeutics' Treasury Shares stood at $3717.0 in 2022, then surged by 44.26% to $5362.0 in 2023, then retreated by 11.81% to $4729.0 in 2024, then surged by 1523.73% to $76786.0 in 2025, then grew by 4.24% to $80045.0 in 2026.
- The last three Treasury Shares figures came in at $80045.0 (Q1 2026), $76786.0 (Q4 2025), and $76861.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Aligos Therapeutics | 54.72 Mn | -25.11 Mn | - | 80,045.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80,045.00 |
| Mar 31, 2026 | 80,045.00 |
| Dec 31, 2025 | 76,786.00 |
| Dec 31, 2025 | 76,786.00 |
| Sep 30, 2025 | 76,861.00 |
| Sep 30, 2025 | 76,861.00 |
| Jun 30, 2025 | 17,264.00 |
| Jun 30, 2025 | 17,264.00 |
| Mar 31, 2025 | 17,264.00 |
| Mar 31, 2025 | 17,264.00 |
| Dec 31, 2024 | 4,729.00 |
| Dec 31, 2024 | 4,729.00 |
| Sep 30, 2024 | 4,429.00 |
| Sep 30, 2024 | 4,429.00 |
| Jun 30, 2024 | 154,580.00 |
| Jun 30, 2024 | 154,580.00 |
| Mar 31, 2024 | 154,580.00 |
| Mar 31, 2024 | 154,580.00 |
| Dec 31, 2023 | 5,362.00 |
| Dec 31, 2023 | 5,362.00 |